共 50 条
Beta-blockers in atrial fibrillation-trying to make sense of unsettling results
被引:14
|作者:
Meyer, Markus
[1
]
Lustgarten, Daniel
[2
]
机构:
[1] Univ Minnesota, Lillehei Heart Inst, Dept Med, 2231 6th St SE, Minneapolis, MN 55455 USA
[2] Univ Vermont, Cardiovasc Res Inst Vermont, Dept Med, Burlington, VT USA
来源:
EUROPACE
|
2023年
/
25卷
/
02期
基金:
美国国家卫生研究院;
关键词:
Heart failure with preserved ejection fraction;
Atrial fibrillation;
Beta-blockers;
Diastolic dysfunction;
HEART;
IVABRADINE;
REDUCTION;
ATENOLOL;
OUTCOMES;
D O I:
10.1093/europace/euad010
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.
引用
收藏
页码:260 / 262
页数:3
相关论文